Chemours (CC)

• Market cap: $1.69B
• 1 day: -0.35%
• 5 days: -2.58%
• 1 month: -19.72%
• 3 months: -43.14%
• 6 months: -40.01%
• Year to date: -32.26%
• 1 year: -57.17%
• 5 years: 11.20%
• 10 years: -45.71%
• Sector: Materials
• Industry: Specialty Chemicals

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

268% more call options, than puts

Call options by funds: $71.5M | Put options by funds: $19.4M

49% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 53

40% more repeat investments, than reductions

Existing positions increased: 141 | Existing positions reduced: 101

3.9% more ownership

Funds ownership: 80.42% [Q3] → 84.32% (+3.9%) [Q4]

4% more funds holding

Funds holding: 418 [Q3] → 434 (+16) [Q4]

13% less capital invested

Capital invested by funds: $2.44B [Q3] → $2.13B (-$310M) [Q4]

17% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 5 (-1) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $16 41% upside
• Avg. target: $21 86% upside
• High target: $27 139% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Truist Securities Peter Osterland 0% 1-year accuracy 0 / 13 met price target	94% upside $22	Buy Maintained	14 Apr 2025
Barclays Michael Leithead 21% 1-year accuracy 4 / 19 met price target	41% upside $16	Equal-Weight Maintained	1 Apr 2025
Mizuho John Roberts 8% 1-year accuracy 3 / 39 met price target	68% upside $19	Outperform Upgraded	27 Mar 2025
BMO Capital John McNulty 20% 1-year accuracy 9 / 46 met price target	139% upside $27	Outperform Maintained	19 Feb 2025